PLATELET-AGGREGATION AND PLASMA-LEVELS OF ACETYLSALICYLIC-ACID IN STROKE PATIENTS ON LONG-TERM TREATMENT WITH AN ENTERIC-COATED ASPIRIN FORMULATION

被引:6
作者
BRITTON, M
MELANDER, A
SVENSSON, J
WAHLINBOLL, E
机构
[1] LUND UNIV,HLTH SCI CTR,DIV CLIN PHARMACOL,DALBY,SWEDEN
[2] UNIV LUND,HLTH SCI CTR,DIV CLIN PHARMACOL,S-22101 LUND,SWEDEN
关键词
D O I
10.1007/BF00542177
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:363 / 365
页数:3
相关论文
共 8 条
[1]   PLASMA ACETYLSALICYLATE AND SALICYLATE AND PLATELET CYCLOOXYGENASE ACTIVITY FOLLOWING PLAIN AND ENTERIC-COATED ASPIRIN [J].
ALI, M ;
MCDONALD, JWD ;
THIESSEN, JJ ;
COATES, PE .
STROKE, 1980, 11 (01) :9-13
[2]  
BIGGS DF, 1977, CAN J PHARM SCI, V12, P23
[3]   BIOAVAILABILITY OF ACETYLSALICYLIC-ACID AND SALICYLIC-ACID FROM RAPID-RELEASE AND SLOW-RELEASE FORMULATIONS, AND IN COMBINATION WITH DIPYRIDAMOL [J].
BRANTMARK, B ;
WAHLINBOLL, E ;
MELANDER, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) :309-314
[4]   INFLUENCE OF FOOD AND FLUID INGESTION ON ASPIRIN BIOAVAILABILITY [J].
KOCH, PA ;
SCHULTZ, CA ;
WILLS, RJ ;
HALLQUIST, SL ;
WELLING, PG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) :1533-1535
[5]   KINETICS OF ASPIRIN, SALICYLIC-ACID, AND SALICYLURIC ACID FOLLOWING ORAL-ADMINISTRATION OF ASPIRIN AS A TABLET AND 2 BUFFERED SOLUTIONS [J].
MASON, WD ;
WINER, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (03) :262-265
[6]   PLASMA-LEVELS OF ASPIRIN FOLLOWING EFFERVESCENT AND ENTERIC COATED TABLETS, AND THEIR EFFECT ON PLATELET-FUNCTION [J].
ROSSLEE, LM ;
ELMS, MJ ;
CHAM, BE ;
BOCHNER, F ;
BUNCE, IH ;
EADIE, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (06) :545-551
[7]   ENTERIC-COATED ASPIRIN AND CYCLOOXYGENASE INHIBITION [J].
SVENSSON, J ;
METTINGER, KL ;
BLOMBACK, M .
THROMBOSIS RESEARCH, 1983, 29 (01) :99-102
[8]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ACETYLSALICYLIC-ACID, SALICYLIC-ACID, DIFLUNISAL, INDOMETHACIN, INDOPROFEN AND INDOBUFEN [J].
WAHLINBOLL, E ;
BRANTMARK, B ;
HANSON, A ;
MELANDER, A ;
NILSSON, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (05) :375-378